Decision To Evaluate and Petition To Designate a Class of Employees at Harshaw Chemical Company (Also Known as Uranium Refinery and/or Harshaw Filtrol Partners), Cleveland, OH, To Be Included in the Special Exposure Cohort, 44298 [06-6683]
Download as PDF
44298
Federal Register / Vol. 71, No. 150 / Friday, August 4, 2006 / Notices
National Institute for Occupational
Safety and Health, 4676 Columbia
Parkway, MS C–46, Cincinnati, OH
45226, Telephone 513–533–6800 (this is
not a toll-free number). Information
requests can also be submitted by e-mail
to OCAS@CDC.GOV.
Dated: August 1, 2006.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 06–6682 Filed 8–3–06; 8:45 am]
BILLING CODE 4163–19–M
requests can also be submitted by e-mail
to OCAS@CDC.GOV.
requests can also be submitted by e-mail
to OCAS@CDC.GOV.
Dated: August 1, 2006.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 06–6683 Filed 8–3–06; 8:45 am]
John Howard,
Director, National Institute for Occupational
Safety and Health Centers for Disease Control
and Prevention.
[FR Doc. 06–6684 Filed 8–3–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Final Effect of Designation of a Class
of Employees for Addition to the
Special Exposure Cohort
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
Decision To Evaluate and Petition To
Designate a Class of Employees at
Harshaw Chemical Company (Also
Known as Uranium Refinery and/or
Harshaw Filtrol Partners), Cleveland,
OH, To Be Included in the Special
Exposure Cohort
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
gechino on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) gives notice as
required by 42 CFR 83.12(e) of a
decision to evaluate a petition to
designate a class of employees at
Harshaw Chemical Company (also
known as Uranium Refinery and/or
Harshaw Filtrol Partners), to be
included in the Special Exposure Cohort
under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. The initial
proposed definition for the class being
evaluated, subject to revision as
warranted by the evaluation, is as
follows:
Facility: Harshaw Chemical Company.
Location: Cleveland, Ohio.
Job Titles and/or Job Duties: All
workers at Harshaw Chemical Company
plant and the laboratories of the
separate facility located at 1945 East
97th Street.
Period of Employment: January 1,
1942 through November 30, 1949.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health, 4676 Columbia
Parkway, MS C–46, Cincinnati, OH
45226, Telephone 513–533–6800 (this is
not a toll-free number). Information
VerDate Aug<31>2005
22:39 Aug 03, 2006
Jkt 208001
BILLING CODE 4163–19–M
BILLING CODE 4163–19–M
ACTION:
Notice.
SUMMARY: The Department of Health and
Human Services (HHS) gives notice
concerning the final effect of the HHS
decision to designate a class of
employees at the Nevada Test Site
(NTS), Mercury, Nevada, as an addition
to the Special Exposure Cohort (SEC)
under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. On June 26, 2006,
as provided for under 42 U.S.C.
7384q(b), the Secretary of HHS
designated the following class of
employees as an addition to the SEC:
Department of Energy (DOE) employees or
DOE contractor or subcontractor employees
who worked at the Nevada Test Site from
January 27, 1951 through December 31, 1962
for a number of work days aggregating at least
250 work days, either solely under this
employment or in combination with work
days within the parameters (excluding
aggregate work day requirements) established
for other classes of employees included in
the SEC, and who were monitored or should
have been monitored.
This designation became effective on
July 26, 2006, as provided for under 42
U.S.C. 7384l(14)(C). Hence, beginning
on July 26, 2006, members of this class
of employees, defined as reported in
this notice, became members of the
Special Exposure Cohort.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health, 4676 Columbia
Parkway, MS C–46, Cincinnati, OH
45226, Telephone 513–533–6800 (this is
not a toll-free number). Information
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 56 FR
69296, October 20, 1980, as amended
most recently at 71 FR 37080, dated
June 29, 2006) is amended to reflect the
establishment of the Writer-Editor
Services Branch within the Division of
Creative Services, National Center for
Health Marketing, Coordinating Center
for Health Information and Service.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Following the title and functional
statement for the Broadcast Production
and Distribution Branch (CPBHD),
Division of Creative Services (CPBH),
National Center for Health Marketing
(CPB), Coordinating Center for Health
Information and Service (CP), insert the
following:
Writer-Editor Services Branch
(CPBHE). (1) Provides production
editing services for CDC’s information
products; (2) provides production
editing services for MMWR publications,
Emerging Infectious Diseases (EID)
journal, and Preventing Chronic Disease
(PCD) journal; (3) provides substantive
editing services for CDC-authored
written material; (4) provides
copyediting services; (5) provides
proofreading services; (6) provides Web
editing services; (7) provides writing
services, including relevant research;
and (8) provides editorial consulting
services and training in writing and
editing.
Delete item (1) of the functional
statement for the Scientific Publications
Branch (CPBGH), Division of Scientific
Communications (CPBG), and insert the
following: (1) Develops, plans,
coordinates, and produces the MMWR
series, including the MMWR
E:\FR\FM\04AUN1.SGM
04AUN1
Agencies
[Federal Register Volume 71, Number 150 (Friday, August 4, 2006)]
[Notices]
[Page 44298]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6683]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Decision To Evaluate and Petition To Designate a Class of
Employees at Harshaw Chemical Company (Also Known as Uranium Refinery
and/or Harshaw Filtrol Partners), Cleveland, OH, To Be Included in the
Special Exposure Cohort
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) gives notice
as required by 42 CFR 83.12(e) of a decision to evaluate a petition to
designate a class of employees at Harshaw Chemical Company (also known
as Uranium Refinery and/or Harshaw Filtrol Partners), to be included in
the Special Exposure Cohort under the Energy Employees Occupational
Illness Compensation Program Act of 2000. The initial proposed
definition for the class being evaluated, subject to revision as
warranted by the evaluation, is as follows:
Facility: Harshaw Chemical Company.
Location: Cleveland, Ohio.
Job Titles and/or Job Duties: All workers at Harshaw Chemical
Company plant and the laboratories of the separate facility located at
1945 East 97th Street.
Period of Employment: January 1, 1942 through November 30, 1949.
FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of
Compensation Analysis and Support, National Institute for Occupational
Safety and Health, 4676 Columbia Parkway, MS C-46, Cincinnati, OH
45226, Telephone 513-533-6800 (this is not a toll-free number).
Information requests can also be submitted by e-mail to OCAS@CDC.GOV.
Dated: August 1, 2006.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 06-6683 Filed 8-3-06; 8:45 am]
BILLING CODE 4163-19-M